Gamma-Aminobutyric Acid
GABA (γ-aminobutyric acid) is the major inhibitory neurotransmitter in the central nervous system, balancing excitatory glutamate signaling. Endogenous GABA does not cross the blood-brain barrier well - this is a frequently-cited reason why supplemental GABA's effects are debated. However, multiple human studies show GABA supplementation produces measurable EEG changes (alpha activity increase) and subjective relaxation/anxiety reduction, suggesting either limited BBB transport, peripheral GABAergic effects (gut-brain axis via vagal afferents), or placebo plus enteric nervous system effects.
30-60 min before sleep or stressful event.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
Mechanism is debated due to limited BBB penetration:
Some BBB penetration may occur via specific GABA transporters; effect size unclear at supplement doses.
GABA receptors in the gut and vagal afferents may signal to brain via gut-brain axis, producing relaxation effects without requiring BBB crossing.
GABA receptors on peripheral tissues (liver, pancreas, muscle) - clinical relevance to subjective effects unclear.
Multiple human studies show oral GABA increases EEG alpha activity (relaxation marker) and decreases beta activity (alert/anxious marker) within 30-60 minutes.
Modest acute cortisol reduction in stress-test paradigms.
30-60 min onset.
1-3 hour functional effect.
Cumulative use: similar profile.
Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.
Oral GABA increased EEG alpha waves and decreased beta waves within 60 minutes.
After 60 minutes of administration, GABA significantly increases alpha waves and decreases beta waves compared to water or L-theanine.
Evidence scope. Human EEG substudy, n=13; dose absent; does not prove BBB penetration.
Claims we could not support
No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.
Dose/route: 100-250 mg oral/sublingual 1-3x/day. No checked sentence verified the full regimen.
Direct BBB or vagal/enteric mechanism. The EEG effect does not identify transport.
Primary safety/no dependence. No checked abstract established this reassuring profile.
Plasma
Post-ingestion
Functional
Oral moderate; BBB penetration debated
Per dose
Hepatic and tissue
Storage. Capsule. Cool dry location.
Dietary supplement (US, DSHEA). EU: classification varies.
Put it to work
Open GABA straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open GABA in the app →Go deeper
The complete GABA walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗Track it in OnePin. Log vials, draws, and protocols in the app.
Type a name, brand, or tool. Esc closes.